Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diagnostic Imaging

Free Subscription Articles published in Lancet Retrieve available abstracts of 63 articles: HTML format

Single Articles

August 2026
1. HARADA-SHOJI N, Suzuki A, Ishida T, Yamamoto S, et al
   Adjunctive ultrasonography in breast cancer screening: the J-START trial - Authors' reply.
   Lancet. 2026;408:697-698.
   PubMed    
   
   
   
2. FUSHIMI A
   Adjunctive ultrasonography in breast cancer screening: the J-START trial.
   Lancet. 2026;408:697.
   PubMed    
   
   
   
3. JING S, Song J
   Adjunctive ultrasonography in breast cancer screening: the J-START trial.
   Lancet. 2026;408:696-697.
   PubMed    
   
   
   
4. MACIOS A, Bretthauer M, Kalager M
   Adjunctive ultrasonography in breast cancer screening: the J-START trial.
   Lancet. 2026;408:696.
   PubMed    
   
   
   July 2026
5. SHINAMAN G, Lewandowski E, Wozniak G, Guo J, et al
   A case of acute necrotising encephalitis secondary to human herpesvirus 6 infection.
   Lancet. 2026;408:183-186.
   PubMed     Abstract available
   
   
   June 2026
6. GOMMERS J, Hernstrom V, Josefsson V, Sartor H, et al
   AI-supported mammography screening: measuring benefit - Authors' reply.
   Lancet. 2026;407:2605-2606.
   PubMed    
   
   
   
7. JENA PK, Shukla S, Pinnamaneni R
   AI-supported mammography screening: measuring benefit.
   Lancet. 2026;407:2605.
   PubMed    
   
   
   
8. CHU Y, Niu C, Jin W
   AI-supported mammography screening: measuring benefit.
   Lancet. 2026;407:2604.
   PubMed    
   
   
   
9. SILIPIGNI S, Soraci L, Gembillo G
   AI-supported mammography screening: measuring benefit.
   Lancet. 2026;407:2603-2604.
   PubMed    
   
   
   May 2026
10. GIOVANNONI G, Airas L, Bove R, Cutter GR, et al
    Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
    Lancet. 2026;407:2195-2207.
    PubMed     Abstract available
    
    
    
11. THERRIAULT J
    Advancing tau-PET imaging in Alzheimer's disease.
    Lancet. 2026;407:2148-2149.
    PubMed    
    
    
    
12. LEE JM, Lee SH, Gim DH, Lee SY, et al
    Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea.
    Lancet. 2026 May 21:S0140-6736(26)00666-5. doi: 10.1016/S0140-6736(26)00666.
    PubMed     Abstract available
    
    
    
13. SARRAJ A, Thomalla G, Yoshimura S, Huo X, et al
    Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.
    Lancet. 2026 May 7:S0140-6736(26)00876-7. doi: 10.1016/S0140-6736(26)00876.
    PubMed     Abstract available
    
    
    April 2026
14. GRAUPERA I, Thiele M, Castera L, Pera G, et al
    Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.
    Lancet. 2026;407:1448-1458.
    PubMed     Abstract available
    
    
    
15. VAN DER BIJL P, Bax JJ
    Contemporary non-invasive imaging for coronary artery disease - Authors' reply.
    Lancet. 2026;407:1425.
    PubMed    
    
    
    
16. HUNYOR I, Wilcox I, O'Sullivan J
    Contemporary non-invasive imaging for coronary artery disease.
    Lancet. 2026;407:1424.
    PubMed    
    
    
    
17. ZHENG H
    Contemporary non-invasive imaging for coronary artery disease.
    Lancet. 2026;407:1424.
    PubMed    
    
    
    
18. TOPOL EJ
    Mammography should include artificial intelligence support.
    Lancet. 2026;407:1415.
    PubMed    
    
    
    
19. HOLCK EN, Holm NR, Hildick-Smith D, Lindsay MM, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.
    Lancet. 2026;407:1374-1382.
    PubMed     Abstract available
    
    
    March 2026
20. ZHU Y, Cheng Z, Zhao Y, Han L, et al
    Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-
    Lancet. 2026;407:1161-1170.
    PubMed     Abstract available
    
    
    February 2026
21. HARADA-SHOJI N, Suzuki A, Ishida T, Yamamoto S, et al
    Cumulative incidence of advanced breast cancer in women aged 40-49 years in the Japan Strategic Anti-cancer Randomised Trial (J-START) of adjunctive ultrasonography: a prespecified secondary analysis.
    Lancet. 2026;407:784-793.
    PubMed     Abstract available
    
    
    
22. SEELY JM, Gordon PB
    Supplemental ultrasound screening lowers advanced breast cancers.
    Lancet. 2026;407:737-738.
    PubMed    
    
    
    January 2026
23. GOMMERS J, Hernstrom V, Josefsson V, Sartor H, et al
    Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy tria
    Lancet. 2026;407:505-514.
    PubMed     Abstract available
    
    
    December 2025
24. GOADSBY J, Syngelaki A, Magee LA, von Dadelszen P, et al
    Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial.
    Lancet. 2025 Dec 4:S0140-6736(25)01207-3. doi: 10.1016/S0140-6736(25)01207.
    PubMed     Abstract available
    
    
    November 2025
25. VAN DER BIJL P, Gulati M, Saraste A, Marwick T, et al
    Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease.
    Lancet. 2025;406:2577-2587.
    PubMed     Abstract available
    
    
    May 2025
26. GILBERT FJ, Payne NR, Allajbeu I, Yit L, et al
    Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial.
    Lancet. 2025 May 21:S0140-6736(25)00582-3. doi: 10.1016/S0140-6736(25)00582.
    PubMed     Abstract available
    
    
    
27. HOUSSAMI N
    Breast cancer screening at a crossroads: supplemental imaging for dense breasts.
    Lancet. 2025 May 21:S0140-6736(25)00803-7. doi: 10.1016/S0140-6736(25)00803.
    PubMed    
    
    
    March 2025
28. SERRUYS PW, Tsai TY, Revaiah PC
    Achieve more with less metal in PCI: angiography-derived FFR, intravascular ultrasound, or both?
    Lancet. 2025 Mar 28:S0140-6736(25)00576-8. doi: 10.1016/S0140-6736(25)00576.
    PubMed    
    
    
    
29. HU X, Zhang J, Yang S, Jiang J, et al
    Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00504-5. doi: 10.1016/S0140-6736(25)00504.
    PubMed     Abstract available
    
    
    
30. FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al
    Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505.
    PubMed     Abstract available
    
    
    
31. ELIA-ZUDAIRE O, Tirado-Galindo M
    Towards a European imaging infrastructure for Alzheimer's disease.
    Lancet. 2025;405:779.
    PubMed    
    
    
    February 2025
32. ARGENTESI G, Wu X, Ney A, Goodchild E, et al
    Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial.
    Lancet. 2025 Feb 7:S0140-6736(24)02755-7. doi: 10.1016/S0140-6736(24)02755.
    PubMed     Abstract available
    
    
    
33. DUNN JA, Donnelly P, Elbeltagi N, Marshall A, et al
    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial.
    Lancet. 2025;405:396-407.
    PubMed     Abstract available
    
    
    January 2025
34. WILLIAMS MC, Wereski R, Tuck C, Adamson PD, et al
    Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
    Lancet. 2025;405:329-337.
    PubMed     Abstract available
    
    
    
35. VILLINES TC
    Durability of patient benefit from CT-guided chest pain management.
    Lancet. 2025;405:278-279.
    PubMed    
    
    
    
36. NAVARRO-COMPAN V, Sepriano A, Capelusnik D, Baraliakos X, et al
    Axial spondyloarthritis.
    Lancet. 2025;405:159-172.
    PubMed     Abstract available
    
    
    October 2024
37. ANDERSEN BK, Sejr-Hansen M, Maillard L, Campo G, et al
    Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.
    Lancet. 2024 Oct 29:S0140-6736(24)02175-5. doi: 10.1016/S0140-6736(24)02175.
    PubMed     Abstract available
    
    
    August 2024
38. CASADO-NARANJO I, Portilla-Cuenca JC, Duarte-Martin JJ, Moyano-Calvente SL, et al
    Multiple intracerebral haemorrhages and ubiquitous brain microbleeds in a patient with Down syndrome: cerebral amyloid angiopathy.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
39. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
    Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
    PubMed     Abstract available
    
    
    
40. MAMAS MA, Mintz GS
    Optical coherence tomography imaging for complex percutaneous coronary intervention.
    Lancet. 2024 Aug 30:S0140-6736(24)01593-9. doi: 10.1016/S0140-6736(24)01593.
    PubMed    
    
    
    
41. FIGUERAS F, Rial-Crestelo M, Gratacos E
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial - Authors' reply.
    Lancet. 2024;404:751-752.
    PubMed    
    
    
    
42. GILES-CLARK HJ, Rolnik DL, Hodges RJ, Skinner SM, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:750.
    PubMed    
    
    
    
43. BACON I, Hezelgrave NL, Cerdeira AS, Mylrea-Foley B, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:750-751.
    PubMed    
    
    
    
44. KAMIHARA Y, Nagase H, Ishikawa H
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:749-750.
    PubMed    
    
    
    
45. MEIJERINK L, Terstappen F, Depmann M, Bekker M, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:749.
    PubMed    
    
    
    
46. BORNSTEIN E, Vintzileos A
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:748-749.
    PubMed    
    
    
    
47. FERREIRA J, Velazquez PP, Zaromytidou M, Montrasio G, et al
    Fibrofatty involution of rhabdomyomas: a longitudinal series of cardiac MRI studies in a patient with possible tuberous sclerosis complex.
    Lancet. 2024;404:692-693.
    PubMed    
    
    
    
48. MESSAS E, Ijsselmuiden A, Trifunovic-Zamaklar D
    Limitations of non-invasive ultrasound therapy for valve stenosis - Authors' reply.
    Lancet. 2024;404:654.
    PubMed    
    
    
    
49. KOMAMURA K, Miyake H, Kobayashi K, Iwase M, et al
    Limitations of non-invasive ultrasound therapy for valve stenosis.
    Lancet. 2024;404:653-654.
    PubMed    
    
    
    
50. OU D, Hu C, Huang S
    Limitations of non-invasive ultrasound therapy for valve stenosis.
    Lancet. 2024;404:653.
    PubMed    
    
    
    July 2024
51. LI M, Kim JB, Sastry BKS, Chen M, et al
    Infective endocarditis.
    Lancet. 2024;404:377-392.
    PubMed     Abstract available
    
    
    
52. BHIDE P, Chan DYL, Lanz D, Alqawasmeh O, et al
    Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT): a multicentre, three-parallel-group, double-blind, randomised controlled trial.
    Lancet. 2024;404:256-265.
    PubMed     Abstract available
    
    
    May 2024
53. DE OLIVEIRA FRANCO A, Uberti Dos Santos V, von Ameln Lovison O, Zavascki AP, et al
    Invasive liver abscess syndrome with central nervous system involvement caused by hypermucoviscous Klebsiella pneumoniae: positive string test.
    Lancet. 2024;403:2257-2258.
    PubMed    
    
    
    
54. TOPOL EJ
    AI-enabled opportunistic medical scan interpretation.
    Lancet. 2024;403:1842.
    PubMed    
    
    
    
55. PONSSEN D, Joseph AA, Neef NE, Frahm J, et al
    Visualising the dynamic morphology of stuttering using real-time MRI.
    Lancet. 2024;403:1789-1790.
    PubMed    
    
    
    April 2024
56. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    PubMed     Abstract available
    
    
    
57. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    PubMed    
    
    
    March 2024
58. RAKOCZY EP
    The promise of long-term treatment for neovascular age-related macular degeneration.
    Lancet. 2024 Mar 27:S0140-6736(24)00428-8. doi: 10.1016/S0140-6736(24)00428.
    PubMed    
    
    
    
59. BURKI T
    Research in Focus: Gates MRI.
    Lancet. 2024;403:1126.
    PubMed    
    
    
    
60. CHEW EY
    Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration.
    Lancet. 2024 Mar 7:S0140-6736(24)00229-0. doi: 10.1016/S0140-6736(24)00229.
    PubMed    
    
    
    
61. GABRIELLE PH, Creuzot-Garcher C
    Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
    Lancet. 2024 Mar 7:S0140-6736(23)02760-5. doi: 10.1016/S0140-6736(23)02760.
    PubMed    
    
    
    February 2024
62. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
    PubMed    
    
    
    
63. STONE GW, Christiansen EH, Ali ZA, Andreasen LN, et al
    Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
    Lancet. 2024 Feb 21:S0140-6736(23)02454-6. doi: 10.1016/S0140-6736(23)02454.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum